Cutaneous Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cutaneous Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC) [Phase 2]
Phase 2 neoadjuvant trial of pembrolizumab in PD-1-naive cutaneous squamous cell carcinoma. Results have been posted in May 2025.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Towards Cure Via Only Ultra-short ICB in CSCC [Phase 2]
The Netherlands Cancer Institute is conducting a Phase 2 trial in cutaneous squamous cell carcinoma using ultra-short immune checkpoint bloc…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating lenvatinib in combination with cetuximab in patients with advanc…
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]
A Phase 2 trial evaluating immunotherapy after organ transplantation to prevent skin cancer in transplant recipients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]
A Phase 2 trial evaluating immunotherapy before transplantation to prevent skin cancer in organ transplant recipients has been withdrawn, wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 window-of-opportunity trial evaluating topical tranexamic acid for cutaneous squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors [Phase 1]
Phase 1 study of TBio-6517 alone or in combination with pembrolizumab in solid tumors was terminated.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
This clinical trial update describes complications and recurrences after Mohs micrographic surgery and Slow Mohs for skin cancers, including…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Needs and Preferences of Patients With Head-neck Cutaneous SCC
A clinical trial investigating the needs and preferences of patients with cutaneous squamous cell carcinoma of the head and neck; the study …
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Interobserver Variability Desmoplasia
A clinical trial evaluating interobserver variability in desmoplasia assessment has completed, focusing on cutaneous squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: OCT and Invasion in Cutaneous Skin Lesions
A completed clinical trial from Maastricht University Medical Center evaluating OCT imaging and invasion in cutaneous skin lesions. The stud…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC. [Phase 1, Phase 2]
A single-center Phase 1/2 trial is evaluating the safety and effects of combining a ketogenic diet with immunotherapy in adults with advance…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study
An observational study assessing the usefulness of post-operative radiotherapy for high-grade cutaneous squamous cell carcinoma, currently r…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma [Phase 2]
Clinical trial update indicates a Phase 2 study of cemiplimab as neoadjuvant plus adjuvant therapy for Cutaneous Squamous Cell Carcinoma is …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
A European registry platform is collecting real-world treatment data for patients with advanced non-melanoma skin cancer, focusing on basal …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin [Phase 1]
Phase 1 intratumoral study of SL-172154 in cutaneous squamous cell carcinoma and squamous cell carcinoma of the head and neck was terminated…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial [Phase 3]
A Phase 3 pivotal trial evaluating nicotinamide for chemoprevention of keratinocyte carcinoma in solid organ transplant recipients is curren…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. [Phase 2]
Phase 2 non-comparative trial evaluating IFX-1 alone or with pembrolizumab in locally advanced or metastatic cutaneous squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
This update reports results from a Phase 2 neoadjuvant trial of atezolizumab for surgically resectable advanced cutaneous squamous cell carc…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer [Phase 2]
Phase 2 clinical trial update evaluating cemiplimab alone and in combination with RP1 for advanced cutaneous squamous cell carcinoma. The st…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 study of ruxolitinib in solid organ transplant recipients with advanced cutaneous squamous cell carcinoma was terminated, and resu…
-
FDA approval · 2024-12-13FDA Approved: UNLOXCYT — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves UNLOXCYT (cosibelimab) in an original application from Sun Pharmaceutical for metastatic cutaneous squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 study of REGN2810 in patients with advanced cutaneous squamous cell carcinoma has completed, with results posted in December 2024.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Deep sequencIng in Cutaneous Squamous CEll caRciNomas [Phase 2]
Phase 2 clinical trial update exploring deep sequencing in cutaneous squamous cell carcinoma and cutaneous squamous cell carcinoma of the he…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers [Phase 1]
Phase 1 clinical trial update on the IFx-Hu2.0 vaccine for advanced non-melanoma skin cancers, including Merkel cell carcinoma and cutaneous…